Relating to this concept, in opposition to the benefits of vagal inhibition in GC progression, some others suggest that α7nAChR signaling as well as high vagal activity predicts better cancer prognosis and also determined the increased risk of cancer mortality after vagotomy [69, 70]. This evidence concerns the gene CHRNA7 and cancer.